Shouyao Holdings (688197) Stock Overview

Shouyao Holdings (Beijing) Co., Ltd. engages in the research, development, and production of pharmaceutical drugs in China. The company offers products for various indications, such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma; pancreatic, breast, ovarian, and thyroid cancer; leukemia, and diabetes. Shouyao Holdings (Beijing) Co., Ltd. was founded in 2016 and is headquartered in Beijing, China.